AI assistant
Sending…
Nykode Therapeutics ASA — Share Issue/Capital Change 2021
May 7, 2021
3695_dirs_2021-05-07_2a4e2e93-5a46-446c-943c-084e945cab0b.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Mandatory notification of exercise of warrants
Mandatory notification of exercise of warrants
Primary insider Agnete B. Fredriksen, President and CSO, has today exercised a total of 330,000 warrants with expiry date of May 13, 2021. The 330,00 shares have been subscribed for at a strike price of NOK 0.65 per share.
Please see further details in attached document
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30